Desde el análisis biomecánico óseo de koch hasta el manejo contemporáneo de la fractura del fémur proximal / From koch's bone biomechanical analysis to contemporary proximal femur fracture management

Este artículo representa una revisión actual y completa de las fuerzas biomecánicas en el fémur proximal, tal como Koch presentó preliminarmente en su trabajo sobre la arquitectura ósea del fémur proximal. Su trabajo reflejó en la complejidad de las fracturas de fémur proximal y el manejo de las fracturas subtrocantéricas en paralelo con su clasificación y con la evolución de implantes. Existen múltiples formas de clasificar las fracturas subtrocantéricas; sin embargo, no existe un sistema de clasificación que se utilice para guiar el manejo quirúrgico. El tratamiento de las fracturas subtrocantéricas es la fijación quirúrgica, que implica el enclavado endomedular y placas de osteosíntesis. El tratamiento estándar es el enclavado endomedular con opciones de enclavado anterógrado y retrógrado. Aunque el enclavado anterógrado presenta una ventaja debido a las fuerzas deformantes, el enclavado retrógrado de las fracturas de fémur proximal ofrece menos tiempo quirúrgico y pérdida de sangre. Se han informado resultados similares entre los dos métodos. La toma de decisiones cuando se contempla el enclavado anterógrado versus retrógrado para las fracturas de fémur se basa principalmente en la constitución corporal y las lesiones asociadas, y no en la distancia de la fractura del fémur proximal a la región trocantérica

This article presents a current and comprehensive review of the biomechanical forces on the proximal femur, as preliminarily presented by Koch's cornerstone work on the bone architecture of the proximal femur. His work reflected on the complexity of proximal femur fractures and subtrochanteric fracture management in parallel with implant evolution and classification. Multiple ways of classifying subtrochanteric fractures exist, however, there is not one classification system that is used to guide operative management. The management of subtrochanteric fractures is surgical fixation which involves intramedullary nailing and plating (e.g., fixed angle and locking). The gold standard management is intramedullary nailing with antegrade and retrograde nail options. Though antegrade nailing presents an advantage due to the deforming forces, retrograde nailing of proximal femur fractures offers less operative time and blood loss. Similar outcomes have been reported between the two methods. Decision making when contemplating antegrade versus retrograde nailing for femur fractures is mostly driven by body habitus and associated injuries, and not by fracture distance of the proximal femur to the trochanteric region

Topical Application of Wogonin Provides a Novel Treatment of Knee Osteoarthritis.

Osteoarthritis (OA) is a degenerative joint disease characterized by inflammatory degradation of articular cartilage and subchondral bone. Wogonin, a compound extracted from the plant Scutellaria baicalensis (colloquially known as skullcap), has previously been shown to have direct anti-inflammatory and antioxidative properties. We examined the pain-reducing, anti-inflammatory, and chondroprotective effects of wogonin when applied as a topical cream. We validated the efficacy of delivering wogonin transdermally in a cream using pig ear skin in a Franz diffusion system. Using a surgical mouse model, we examined the severity and progression of OA with and without the topical application of wogonin. Using a running wheel to track activity, we found that mice with wogonin treatment were statistically more active than mice receiving vehicle treatment. OA progression was analyzed using modified Mankin and OARSI scoring and direct quantification of cyst-like lesions at the chondro-osseus junction; in each instance we observed a statistically significant attenuation of OA severity among mice treated with wogonin compared to the vehicle treatment. Immunohistochemistry revealed a significant decrease in protein expression of transforming growth factor ß1 (TGF-ß1), high temperature receptor A1 (HTRA1), matrix metalloprotease 13 (MMP-13) and NF-κB in wogonin-treated mice, further bolstering the cartilage morphology assessments in the form of a decrease in inflammatory and OA biomarkers.